Pretreatment with P2Y 12 Receptor Inhibitors in Acute Coronary Syndromes—Is the Current Standpoint of ESC Experts Sufficiently Supported? Excessive platelet reactivity plays a pivotal role in the pathogenesis of acute myocardial infarction. Today, the vast majority of patients presenting with... P Niezg...
Letter--Prudent Formulary Management or Underutilization of the Novel P2Y12 Receptor Inhibitors in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention? DISCLOSURES: The author is a former employee of AstraZeneca and owns stock in AstraZeneca. The author reports no conflic...
The Ca2+ response to VEGF is also sensitive to angiogenesis inhibitors, such as angiostatin and endostatin, which are necessary for vessel pruning and regression of selected vascular branches [12]. Angiostatin comprises of the first four-kringle domains of plasminogen, which is a quite abundant ...